COVID-19 Content: An AHA Compendium

The American Heart Association is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.


AHA Center for Health Metrics and Evaluation

COVID-19 Data Challenge

The COVID-19 Data Challenge asks participants to use the AHA's Precision Medicine Platform (PMP) to test the relationships between COVID-19, other health conditions, health disparities and social determinants of health using their own data and/or data available on the Precision Medicine Platform.

Stage 1: May 12 - July 12, 2020
Stage 2: Sept. 1 - Nov. 1, 2020

Stroke Community

Join the AHA and front-line experts as we discuss COVID-19's impact on stroke

Webinar: Stroke and COVID-19: Cases from the Frontlines — Case presentations and panel discussion
Date: Thursday, May 21, 2020
Time: 11:00 a.m. – 12:00 p.m. CDT

  • Steven Feske, MD, Brigham and Women’s Hospital, Boston, MA
  • Bay Leslie-Mazwi, MD, Massachusetts General Hospital, Boston, MA
  • Brett L. Cucchiara, MD, The Hospital of the University of Pennsylvania, Philadelphia, PA

Featured Videos

Cardiac Implications of Non-Cardiac Disease: AHA COVID-19 CVD Registry

New this week! William Borden, MD, FAHA interviews Sandeep Das, MD, MPH about AHA's new COVID-19 CVD registry to collect data about COVID-19 and its impact on CV health, which he reviewed during a QCOR 2020 session on the cardiac implications of non-cardiac disease.

Learn more about the COVID-19 Data Challenge.

COVID | Updates from the Front Lines | Mt. Sinai, New York

CIRCULATION COVID Team member Adedapo Iluyomade, MD, MBA interviews Eric Legome, MD, Chair Mt. Sinai West and St. Luke's Hospital about how the COVID pandemic has impacted the emergency department at his institution.

View the full COVID | Updates from the Front Lines video series

Answers to questions about COVID-19 and heart valve disease

Suzanne Arnold, MD, FAHA answers questions about COVID-19 for those living with heart valve disease and facing treatment for aortic stenosis.

Lawrence Livermore National Labs/AHA COVID-19 Data Portal

New this week! This collaboration on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2.

This searchable data portal houses a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based "virtual" screening of interactions with SARS-CoV-2 viral proteins for drug design purposes.

Beneficial Business Exchange

This new AHA platform is for broad-scaled exchanges between businesses and organizations, not individuals — the focus is on organizational/community needs and helping donors meet those. Help spread the word!

More for Providers